Morphine-specific IgE testing in the assessment of neuromuscular blocking agent allergy. Comment on Br J Anaesth 2024; 132: 193-5.

Ebo, Didier G; Sabato, Vito; Mertens, Christel; Van Gasse, Athina L

Ebo, Didier G; Sabato, Vito; Mertens, Christel; Van Gasse, Athina L.

Afiliación

Ebo DG; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium. Electronic address: immuno@uantwerpen.be.
Sabato V; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium.
Mertens C; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium.
Van Gasse AL; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium; Department of Paediatrics, The Infla-Med Centre of Excellence, Faculty of Medicine and Health S

Br J Anaesth ; 132(5): 976-977, 2024 May.

Article en En | MEDLINE | ID: mdl-38402108

Asunto(s)

Hipersensibilidad; Bloqueantes Neuromusculares; Humanos; Morfina; Codeína; Inmunoglobulina E

Palabras clave

diagnosis; hypersensitivity; morphine; neuromuscular blocking agent; specific IgE

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipersensibilidad / Bloqueantes Neuromusculares Límite: Humans Idioma: En Revista: Br J Anaesth Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google